I spoke to the VP of IR last week.....
He reiterated the guidance provided in the most recent slide deck presentation for the ending of the BETonMACE trial, H1 2019 or June 30th 2019...that is an "expected on or before date". He also said the longer the trial goes on that it will increase the power and statistical significance of the results.
Of course after they stop dosing, then we're looking at another 2-3 months before Top-Line results would be published.
In the interim the company signaled that they are "anticipating" one or more subscriptions for shares/warrants by start of March. Of course with that being forward looking its not written in stone but in pencil. If they haven't arranged financing by the start of March I don't expect we'd see any news with a status update...that's not the way Resverlogix rolls from my experience. It strikes me that we should only expect news when they are absolutely required to put it out.